Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shantou Tuobin Pharmaceutical Factory is a Chinese pharmaceutical company specializing in the development and manufacturing of recombinant DNA products and traditional chemical drugs. The company is best known for its production of recombinant human interferon alpha-2b and alpha-2a, which are used in the treatment of viral infections and various cancers. Tuobin operates large-scale manufacturing facilities that comply with Chinese Good Manufacturing Practice (GMP) standards. Its product portfolio includes a range of anti-infectives, oncology treatments, and dermatological preparations. The company serves both the domestic Chinese market and international markets through its established distribution networks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tuobin Pharmaceutical Factory.